The <scp>HI‐STAR</scp> study: resource utilization and costs associated with serologic testing for antibody‐positive patients at four <scp>U</scp>nited <scp>S</scp>tates medical centers

Abstract

Antibody-positive patients with complex diagnoses or transfusion histories require significantly more resources and incur greater cost to assess red blood cell antibody status.